Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongjiang Xu

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
European Journal of Medicinal Chemistry|February 19, 2018
Design, synthesis and identification of silicon-containing HCV NS5A inhibitors with pan-genotype activityBaomin Liu, Kuo Gai, Hui Qin, et al.
Journal of Medicinal Chemistry|April 16, 2020
Discovery of a Silicon-Containing Pan-Genotype Hepatitis C Virus NS5A InhibitorBaomin Liu, Kuo Gai, Hui Qin, et al.
European Journal of Medicinal Chemistry|April 6, 2012
Novel pyrrolopyrimidine analogues as potent dipeptidyl peptidase IV inhibitors based on pharmacokinetic property-driven optimizationHui Xie, Lili Zeng, Shaogao Zeng, et al.
Bioorganic & Medicinal Chemistry|September 18, 2021
Discovery of potent and selective Bcl-2 inhibitors with acyl sulfonamide skeletonBin Wang, Weiwei Feng, Jinan Wang, et al.
Bioorganic & Medicinal Chemistry|November 4, 2022
Design and synthesis of boron-containing ALK inhibitor with favorable in vivo efficacyJing Ren, Yong Gao, Wei Shi, et al.
Journal of Medicinal Chemistry|July 30, 2025
Discovery of <b>TQ-3959</b> as a Potent and Orally Bioavailable BTK PROTAC Degrader Incorporating a Novel Benzisoxazole-Based CRBN Ligand for the Treatment of B-Cell MalignanciesJing Ren, Yongkang Huang, Jinan Wang, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 2018
Structure-activity relationship study of a series of caspase inhibitors containing γ-amino acid moiety for treatment of cholestatic liver diseaseJianfeng Mou, Songliang Wu, Zhi Luo, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
European Journal of Medicinal Chemistry|February 19, 2018
Design, synthesis and identification of silicon-containing HCV NS5A inhibitors with pan-genotype activityBaomin Liu, Kuo Gai, Hui Qin, et al.
Journal of Medicinal Chemistry|April 16, 2020
Discovery of a Silicon-Containing Pan-Genotype Hepatitis C Virus NS5A InhibitorBaomin Liu, Kuo Gai, Hui Qin, et al.
European Journal of Medicinal Chemistry|April 6, 2012
Novel pyrrolopyrimidine analogues as potent dipeptidyl peptidase IV inhibitors based on pharmacokinetic property-driven optimizationHui Xie, Lili Zeng, Shaogao Zeng, et al.
Bioorganic & Medicinal Chemistry|September 18, 2021
Discovery of potent and selective Bcl-2 inhibitors with acyl sulfonamide skeletonBin Wang, Weiwei Feng, Jinan Wang, et al.
Bioorganic & Medicinal Chemistry|November 4, 2022
Design and synthesis of boron-containing ALK inhibitor with favorable in vivo efficacyJing Ren, Yong Gao, Wei Shi, et al.
Journal of Medicinal Chemistry|July 30, 2025
Discovery of <b>TQ-3959</b> as a Potent and Orally Bioavailable BTK PROTAC Degrader Incorporating a Novel Benzisoxazole-Based CRBN Ligand for the Treatment of B-Cell MalignanciesJing Ren, Yongkang Huang, Jinan Wang, et al.
Bioorganic & Medicinal Chemistry Letters|April 14, 2018
Structure-activity relationship study of a series of caspase inhibitors containing γ-amino acid moiety for treatment of cholestatic liver diseaseJianfeng Mou, Songliang Wu, Zhi Luo, et al.
Pageof 4